Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years
HIV capsid inhibitor offers new option for people with highly resistant HIV
Injectable HIV treatment is coming
Long-acting injectables appear feasible for long-term HIV treatment
Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade
Similar benefits and barriers to injectables for HIV prevention and treatment reported by US women
New once-a-week drug could be part of weekly oral treatment
Long-acting injectables work without oral lead-in period
Injectable HIV therapy should save money if adherence is better than to oral therapies
